Identifying Key Genes Involved in Axillary Lymph Node Metastasis in Breast Cancer Using Advanced RNA-Seq Analysis: A...

Area of Science:

• Oncology
• Bioinformatics
• Genomics

Background:

• RNA-Seq data analysis in cancer studies presents methodological challenges, particularly in identifying genes linked to axillary lymph node metastasis (ALNM).
• Conventional statistical methods often fail to adequately address the discrete and overdispersed nature of RNA-Seq count data.

Purpose of the Study:

• To enhance the identification of key genes involved in breast cancer ALNM.
• To develop a more accurate method for analyzing RNA-Seq data in cancer research.
• To provide insights for early intervention and targeted therapy development.

Main Methods:

• Utilized Generalized Linear Models with Quasi-Likelihood (GLMQLs) to handle RNA-Seq data characteristics.
• Employed Trimmed Mean of M-values (TMMs) for normalization to correct for library-specific compositional biases.
• Focused analysis on a cohort of 104 untreated breast cancer patients from the TCGA BRCA dataset, analyzing protein-coding genes using the Magnitude Altitude Scoring (MAS) system.

Main Results:

• Identified several genes significantly associated with ALNM in breast cancer, including ERBB2, CCNA1, FOXC2, LEFTY2, VTN, ACKR3, and PTGS2.
• Highlighted the involvement of these genes in critical cancer processes such as apoptosis, epithelial-mesenchymal transition, and angiogenesis.
• Emphasized the importance of the small proline-rich protein (SPRR) family (SPRR2B, SPRR2E, SPRR2D) and chromatin-modulating transcripts (H3C10, H1-2, PADI4) in cancer progression.

Conclusions:

• The developed GLMQLs and MAS approach offers a robust method for RNA-Seq data analysis in cancer studies.
• The identified genes provide novel insights into the molecular mechanisms of breast cancer metastasis.
• These findings can contribute to the development of predictive models and targeted therapeutic strategies for ALNM.